Severely calcified lesions are difficult to treat with endovascular techniques.[@bib1]^,^[@bib2] These lesions are highly prevalent in elderly patients and in diabetics, in whom endovascular treatment is preferred.[@bib3] Heavily calcified lesions are difficult to cross and are a hurdle to optimal dilation.[@bib1]

Ichihashi et al[@bib4] developed a technique of percutaneous direct needle puncture of calcified plaque (PIERCE). In this technique, the calcified lesion is percutaneously punctured with a needle, causing a crack in the lesion to facilitate the passage of the device through the lesion.[@bib4] It is a simple and inexpensive technique but is not always successful, partly because of mobility of the vessel.

We developed a novel extension of the PIERCE technique that we termed the direct extravascular calcium interruption arterial procedure (DECIAP). This technique involves percutaneously crushing and therefore modifying the calcified plaque to allow balloon passage or to treat persistent recoil. This report describes the technical aspects of the DECIAP technique performed in four patients.

This study was conducted according to the principles of the Declaration of Helsinki and approved by the Institutional Review Board. Informed consent was obtained from all patients.

Case report {#sec1}
===========

From August 2017 to September 2018, four patients underwent the DECIAP technique, which was performed as a bailout procedure to ensure angiographic success. The DECIAP technique was performed in patients with Rutherford class 5 or class 6 chronic limb-threatening ischemia with the inability to cross a stenotic or occlusive lesion with a low-profile balloon after initial wire passage or with persistent recoil of ≥50% after high-pressure balloon angioplasty or stenting ([Fig 1](#fig1){ref-type="fig"}). The DECIAP technique was performed in the infrapopliteal vessels (n = 3) and in the superficial femoral artery (SFA; n = 1).Fig 1Recoil was seen despite high-pressure noncompliant balloon angioplasty.

Procedural details {#sec1.1}
------------------

All patients were prepared for angioplasty according to the institutional protocol and were pretreated with aspirin (100 mg) before the procedure. All patients underwent a popliteal nerve block for periprocedural and postprocedural pain relief. General anesthesia was used if popliteal anesthesia alone was insufficient. Antegrade access to the femoral artery was obtained, and a 5F or 6F sheath was placed. Systemic anticoagulation was performed with 3000 units of intra-arterially administered unfractionated heparin followed by 1000 units per subsequent hour of intervention according to institutional protocol.

Percutaneous transluminal angioplasty was performed in a standard fashion. SFA lesions were crossed using a 0.018-inch moderate-support guidewire, and infrapopliteal lesions were crossed with a 0.014-inch moderate-support guidewire. When antegrade crossing failed, retrograde access was performed. A low-profile balloon was inserted to cross and to predilate the lesion. High-pressure balloons were used to treat recoil. A stent was inserted when there was ≥50% recoil or dissection.

The PIERCE technique[@bib4] was performed when the balloon was unable to cross the lesion or when recoil could not be treated by a high-pressure noncompliant balloon. This was performed with 16-gauge needles. The decision to use the PIERCE technique before DECIAP was left to the discretion of the operator.

DECIAP technique {#sec1.2}
----------------

Before DECIAP, a low-profile balloon was placed just above the lesion to cross the lesion or to perform balloon-assisted hemostasis. In cases of infrapopliteal lesions, a 1-cm incision was performed directly over the lesion ([Fig 2](#fig2){ref-type="fig"}). A curved surgical artery forceps was introduced, and blunt dissection of the soft tissue was done to arrive just above the surface of the artery. This was confirmed on angiography in two views. The lesion was localized at the center of the fluoroscopy field view to minimize parallax error.Fig 2The direct extravascular calcium interruption arterial procedure (DECIAP) technique. **A,** A 1-cm incision is performed directly over the lesion. **B,** Artery forceps is introduced and positioned above the lesion, as confirmed on an angiogram. **C,** The jaws of the forceps are opened 2 to 3 mm apart, and the walls of the artery are crushed gently (the jaws are not fully closed) between the jaws of the forceps.

The jaws of the forceps were opened 2 or 3 mm apart. The forceps was then advanced deeper, and the walls of the artery were gently crushed between the jaws of the forceps. Successful crushing of the artery was assumed when deviation of the wire was seen in response to the crushing. The movement was performed in a slow, deliberate "kneading" fashion along the length of the lesion. The lesion was crossed with a balloon for balloon hemostasis for 3 minutes. Control angiography was then performed. If any extravasation was seen, prolonged balloon-assisted hemostasis was applied for 3 minutes more. Final balloon angioplasty was performed with a high-pressure noncompliant balloon. The balloon was sized on a 1:1 basis on outer wall direct visualization vs sizing based on luminal diameters of the normal vessel ([Fig 3](#fig3){ref-type="fig"}).Fig 3Angiogram results with a high-pressure noncompliant balloon after the direct extravascular calcium interruption arterial procedure (DECIAP) technique. The lesion is successfully dilated at a lower pressure.

Skin closure was performed with 3-0 interrupted Prolene sutures (Ethicon, Somerville, NJ). After the procedure, heparin was partially reversed at the discretion of the operator. The same technique was applied in the SFA lesions. Procedural details are summarized in the [Table](#tbl1){ref-type="table"}.TablePatients\' characteristics and procedural detailsPatient 1Patient 2Patient 3Patient 4Age, years83837380SexFemaleFemaleMaleFemaleComorbidityHT, HL, DM, CVAHT, HL, DM, IHDHT, HL, DM, CKDHT, HL, DM, AFBody mass index, kg/m^2^21.521.523.628.5Rutherford class5555Indication for DECIAPUnable to cross with low-profile balloonRecoil of SFA post-stenting 50% recoilUnable to cross with low-profile balloonRecoil with high-pressure balloonPIERCE techniqueNot performedPIERCE failedPIERCE failedPIERCE failedTarget vesselATASFAATAATAAnesthesiaRegionalRegionalRegionalRegional converted to generalStenosis or occlusion90% diffuse stenosis, entire length of ATA70% diffuse stenosis, whole SFA90% diffuse stenosis, entire length of ATAOcclusion, lower two-thirds of ATATASC lesionCCCDPARC classification of calcification[@bib5]SevereSevereSevereModerateGuidewire0.014-inch PT2[a](#tbl1fna){ref-type="table-fn"}0.018-inch V18[a](#tbl1fna){ref-type="table-fn"}0.014-inch Command ES[b](#tbl1fnb){ref-type="table-fn"}0.014-inch PT2CrossingAntegrade onlyAntegrade onlyAntegrade onlyRetrogradeBalloons used to cross or to efface lesions before DECIAPArmada XT[b](#tbl1fnb){ref-type="table-fn"} 1.5 × 20 mmMustang[a](#tbl1fna){ref-type="table-fn"} 6 × 80 mm, 24 atmArmada XT 1.5 × 20 mmJADE[c](#tbl1fnc){ref-type="table-fn"} 3 × 120 mm, 24 atmBalloon used for final angioplastyJADE 2.5 × 120 mm, 16 atmMustang 6 × 80 mm, 24 atmJADE 3 × 120 mm, 20 atmJADE 3 × 120 mm, 20 atmHeparin3000 units3000 units3000 units3000 unitsHeparin reversalProtamine, 20 mgProtamine, 20 mgProtamine, 20 mgNo reversalLength of follow-up, days876131113[^1][^2][^3][^4]

Results {#sec2}
=======

A total of four patients were treated with the DECIAP technique. The indications to use the DECIAP technique were failure of crossing with a low-profile balloon (Armada XT \[Abbott Vascular, Abbott Park, Ill\]; n = 2), recoil after stenting (n = 1), and recoil after high-pressure balloon (JADE \[OrbusNeich, Hong Kong\]; n = 1). The technique was performed by vascular surgeons with broad experience in endovascular techniques. After the DECIAP technique, final angioplasty was performed with the JADE balloon with a pressure between 16 and 20 atm in three patients and a Mustang balloon (Boston Scientific, Marlborough, Mass) with a pressure of 24 atm in one patient.

Procedural outcomes {#sec2.1}
-------------------

After the DECIAP technique, optimal balloon angioplasty (recoil of \<30%) was successfully achieved in all patients. In two patients, no residual stenosis was seen on final angiography. In the other two patients, angiographically insignificant residual stenosis of 30% was seen. A small perforation occurred in one patient at the area of the artery where the DECIAP technique was performed. This was resolved with prolonged ballooning for another 3 minutes. One patient died of sepsis 6 days after the procedure. No other adverse events were recorded in the 30 days after the procedure.

No angiographic evidence of distal embolization was seen in any of the patients. Postprocedural surveillance ultrasound imaging did not reveal any aneurysmal change of the vessels treated with DECIAP. One patient required a clinically driven reintervention because of an occlusion that was detected 3 months after the initial procedure. No other reinterventions were performed in the other three patients during the length of follow-up. The ischemic wounds present before the procedure healed at days 87, 113, and 131. In one patient, no wound healing occurred because of death at day 6. All stab incisions made to perform the DECIAP procedure healed during the time of follow-up.

Discussion {#sec3}
==========

DECIAP is an adaptation of a technique that has been described in open surgery to enable clamping of an artery or stitching of an artery in severe calcification. It is an accessible procedure to perform as a bailout option to cross heavily calcified lesions. Other plaque-cracking techniques have been reported by Kawarada et al[@bib6] and Dias-Neto et al.[@bib7] Karawarda et al[@bib6] described the percutaneous intravascular cracking technique. In this technique, the stiff tail of a guidewire is used to crack severely calcified chronic total occlusion lesions. Dias-Neto et al[@bib7] described a retrospective study of the "pave-and-crack" technique in which the lesion is first "cracked" in preparation for the "pave" with a stent. This technique is done by aggressive high-pressure or cutting balloon angioplasty and would therefore not be applicable if balloon crossing is not initially achieved. New treatment modalities, such as lithotripsy, aim to fracture the calcium intravascularly. Although this might be a solution for heavily calcified lesions, its use is accompanied by increased costs, and the safety and efficacy are poorly studied in infrapopliteal arteries.[@bib8]

In our series, the DECIAP technique was used to allow a small low-profile balloon to cross the lesion and to perform predilation or to treat persistent recoil. No major procedure-related events occurred during or after the procedure, and the equipment necessary for the procedure is already present in the interventional suite and therefore does not require capital investment of consoles used in some atherectomy systems.

There are a few drawbacks of the DECIAP technique. The technique is somewhat invasive and may cause injury to surrounding structures. Nerve injury, artery rupture, distal embolism, guidewire fracture, arterial occlusion, arteriovenous fistula, venous thrombosis, bleeding, and infection are all potential risks, most of which were not observed in our study. This technique might not be feasible in obese patients or in arteries that are in a deeper location, for example, proximal to mid SFA and deep posterior tibial or peroneal artery. In addition, the potential for stent fracture exists, but because of our limited experience, we are unable to advise on safety. None of the mentioned risks was seen in our series.

Conclusions {#sec4}
===========

In this initial experience, the DECIAP technique was successful as a bailout option in patients in whom balloon crossing was impossible or recoil was untreatable even with high-pressure balloons. The necessary equipment to perform the technique is readily available. More research is needed in a larger population of patients to clarify the safety and long-term efficacy of the DECIAP technique.
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